{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:59:48Z","timestamp":1790668788703,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Sichuan Traditional Chinese Medicine Administration Research Program","award":["2024MS147"],"award-info":[{"award-number":["2024MS147"]}]},{"name":"the Open Fund of Sichuan Provincial Key Laboratory of Philosophy and Social Sciences for Intelligent Medical Care and Elderly Health Management","award":["ZHYYZKZD2401"],"award-info":[{"award-number":["ZHYYZKZD2401"]}]},{"name":"Scientific Research Project of Sichuan Provincial Medical Association","award":["S2024026"],"award-info":[{"award-number":["S2024026"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-05290-7","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T09:03:41Z","timestamp":1789463021000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical characteristics of metabolic dysfunction-associated steatotic liver disease and its association with significant liver fibrosis in hospitalized patients with chronic hepatitis B: a single-center retrospective cross-sectional study"],"prefix":"10.1186","volume":"26","author":[{"given":"Chun-Xia","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao-Quan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-Feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"issue":"9","key":"5290_CR1","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/S2468-1253(22)00124-8","volume":"7","author":"BS Sheena","year":"2022","unstructured":"Sheena BS, Hiebert L, Han H, Ippolito H, Abbasi-Kangevari M, Abbasi-Kangevari Z, Abbastabar H, Abdoli A, Vos T. Global, regional, and national burden of hepatitis B, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Gastroenterol Hepatol. 2022;7(9):796\u2013829.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"5290_CR2","first-page":"100925","volume":"39","author":"H Perazzo","year":"2024","unstructured":"Perazzo H, Nunes EP, Cardoso SW, Veloso VG, Grinsztejn B. Alignment of countries in the Americas with the latest WHO guidelines for hepatitis B virus (HBV) infection: a review. Lancet Reg Health Am. 2024;39:100925.","journal-title":"Lancet Reg Health Am"},{"issue":"2","key":"5290_CR3","first-page":"205","volume":"41","author":"S Shan","year":"2025","unstructured":"Shan S, Jia J. Advances and challenges in the treatment of chronic hepatitis B in China. J Clin Hepatol. 2025;41(2):205\u20139.","journal-title":"J Clin Hepatol"},{"issue":"39","key":"5290_CR4","doi-asserted-by":"publisher","first-page":"11077","DOI":"10.3748\/wjg.v21.i39.11077","volume":"21","author":"P St\u00e5l","year":"2015","unstructured":"St\u00e5l P. Liver fibrosis in non-alcoholic fatty liver disease - diagnostic challenge with prognostic significance. World J Gastroenterol. 2015;21(39):11077\u201387.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"5290_CR5","doi-asserted-by":"publisher","first-page":"197","DOI":"10.7570\/jomes23052","volume":"32","author":"WK Chan","year":"2023","unstructured":"Chan WK, Chuah KH, Rajaram RB, Lim LL, Ratnasingam J, Vethakkan SR. Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review. J Obes Metab Syndr. 2023;32(3):197\u2013213.","journal-title":"J Obes Metab Syndr"},{"issue":"1","key":"5290_CR6","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1186\/s12889-023-17177-3","volume":"23","author":"B Zhou","year":"2023","unstructured":"Zhou B, Gong N, He Q, Huang X, Zhu J, Zhang L, Huang Y, Tan X, Xia Y, Zheng Y, et al. Clustering of lifestyle behaviours and analysis of their associations with MAFLD: a cross-sectional study of 196,515 individuals in China. BMC Public Health. 2023;23(1):2303.","journal-title":"BMC Public Health"},{"issue":"18","key":"5290_CR7","doi-asserted-by":"publisher","first-page":"5608","DOI":"10.3390\/jcm13185608","volume":"13","author":"F Abu Baker","year":"2024","unstructured":"Abu Baker F, Zeina AR, Taher R, Abu Mouch S, Israel A. Characterizing Unique Clinical and Virological Profiles in Concurrent Chronic Hepatitis B and Metabolic Dysfunction-Associated Liver Disease: Insights from a Population-Based Cohort Study. J Clin Med. 2024;13(18):5608.","journal-title":"J Clin Med"},{"issue":"26","key":"5290_CR8","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.3748\/wjg.v27.i26.3971","volume":"27","author":"YW Shi","year":"2021","unstructured":"Shi YW, Yang RX, Fan JG. Chronic hepatitis B infection with concomitant hepatic steatosis: Current evidence and opinion. World J Gastroenterol. 2021;27(26):3971\u201383.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"5290_CR9","doi-asserted-by":"publisher","first-page":"e70042","DOI":"10.1111\/liv.70042","volume":"45","author":"LA Patmore","year":"2025","unstructured":"Patmore LA, van Eekhout K, Koc \u00d6M, de Knegt RJ, Janssen HLA, Brouwer WP, Kramer M, Honkoop P, de Bruijne J, Boland GJ, et al. The Association Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Change in Liver Stiffness in Patients With Chronic Hepatitis B. Liver Int. 2025;45(3):e70042.","journal-title":"Liver Int"},{"key":"5290_CR10","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.2147\/DMSO.S369824","volume":"15","author":"QX Wang","year":"2022","unstructured":"Wang QX, Xue J, Shi MJ, Xie YB, Xiao HM, Li S, Lin M, Chi XL. Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and the Risk of Cirrhosis in Patients with Chronic Hepatitis B-A Retrospective Cohort Study. Diabetes Metab Syndr Obes. 2022;15:2311\u201322.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"5290_CR11","doi-asserted-by":"publisher","first-page":"733348","DOI":"10.3389\/fcimb.2021.733348","volume":"11","author":"Y Huang","year":"2021","unstructured":"Huang Y, Gan Q, Lai R, Wang W, Guo S, Sheng Z, Chen L, Guo Q, Cai W, Wang H, et al. Application of Fatty Liver Inhibition of Progression Algorithm and Steatosis, Activity, and Fibrosis Score to Assess the Impact of Non-Alcoholic Fatty Liver on Untreated Chronic Hepatitis B Patients. Front Cell Infect Microbiol. 2021;11:733348.","journal-title":"Front Cell Infect Microbiol"},{"issue":"16","key":"5290_CR12","doi-asserted-by":"publisher","first-page":"4738","DOI":"10.3390\/jcm13164738","volume":"13","author":"SA Al-Busafi","year":"2024","unstructured":"Al-Busafi SA, Al Balushi AS, Al Shuaili HH, Mahmood DA, Al Alawi AM. Prevalence of Non-Alcoholic Fatty Liver Disease and Its Impact on Fibrosis Risk in Inactive Chronic Hepatitis B Patients: Insights from a Cross-Sectional Study. J Clin Med. 2024;13(16):4738.","journal-title":"J Clin Med"},{"issue":"3","key":"5290_CR13","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1007\/s40121-022-00629-5","volume":"11","author":"Y Diao","year":"2022","unstructured":"Diao Y, Hu D, Hu X, Wang P, Wang X, Luo X, Wang H, Ning Q. The Role of Metabolic Factors and Steatosis in Treatment-Na\u00efve Patients with Chronic Hepatitis B and Normal Alanine Aminotransferase. Infect Dis therapy. 2022;11(3):1133\u201348.","journal-title":"Infect Dis therapy"},{"issue":"2","key":"5290_CR14","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3350\/cmh.2019.0001n","volume":"26","author":"X Zhang","year":"2020","unstructured":"Zhang X, Wong GL, Wong VW. Application of transient elastography in nonalcoholic fatty liver disease. Clin Mol Hepatol. 2020;26(2):128\u201341.","journal-title":"Clin Mol Hepatol"},{"issue":"6","key":"5290_CR15","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","volume":"79","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, Romero D, Abdelmalek MF, Anstee QM, Arab JP, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79(6):1542\u201356.","journal-title":"J Hepatol"},{"issue":"1","key":"5290_CR16","first-page":"goac005","volume":"10","author":"M Li","year":"2022","unstructured":"Li M, Wan S, Wu X, Lin Y, Wu B. Diagnostic performance of elastography on liver fibrosis in antiviral treatment-naive chronic hepatitis B patients: a meta-analysis. Gastroenterol Rep (Oxf). 2022;10(1):goac005.","journal-title":"Gastroenterol Rep (Oxf)"},{"issue":"3","key":"5290_CR17","first-page":"457","volume":"26","author":"Y Hong","year":"2023","unstructured":"Hong Y, Fusheng W, Taisheng L, Yameng S, Xiaoyuan X, Jidong J, Yuemin N, Guiqiang W, Jinlin H, Lai W, et al. Guidelines for the prevention and treatment of chronic hepatitis B (version 2022). J Pract Hepatol. 2023;26(3):457\u201378.","journal-title":"J Pract Hepatol"},{"issue":"4","key":"5290_CR18","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S0168-8278(24)01508-3","volume":"27","author":"F Jiangao","year":"2024","unstructured":"Jiangao F, Xiaoyuan X, Yuemin N, Lai W, Jidong J, Hui Z, Junping S, Xiaoying L, Chao S, Jie L, et al. Guidelines for the prevention and treatment of metabolic dysfunction-associated (non-alcoholic) fatty liver disease (Version 2024). J Pract Hepatol. 2024;27(4):494\u2013510.","journal-title":"J Pract Hepatol"},{"issue":"11","key":"5290_CR19","first-page":"2408","volume":"35","author":"X Xu","year":"2019","unstructured":"Xu X, Ding H, Li W, Xu J, Han Y, Jia J, Wei L, Duan Z, Linghu E, Zhuang H. Chinese guidelines on the management of liver cirrhosis. J Clin Hepatol. 2019;35(11):2408\u201325.","journal-title":"J Clin Hepatol"},{"issue":"10","key":"5290_CR20","first-page":"2163","volume":"35","author":"L Lungen","year":"2019","unstructured":"Lungen L, Hong Y, Weifen X, Jidong J. Consensus on the diagnosis and therapy of hepatic fibrosis(2019). J Clin Hepatol. 2019;35(10):2163\u201372.","journal-title":"J Clin Hepatol"},{"issue":"3","key":"5290_CR21","first-page":"35","volume":"50","author":"Z Chunxia","year":"2024","unstructured":"Chunxia Z, Liang W, Tianfu L, Juan L, Yuanyuan L, Zhiyan P, Lingyi Z. To compare the diagnostic efficacy of liver stiffness measurement and serological model for liver fibrosis in CHB patients with maintained virologic response based on liver biopsy. J Lanzhou University(Medical Sciences). 2024;50(3):35\u201343.","journal-title":"J Lanzhou University(Medical Sciences)"},{"issue":"1","key":"5290_CR22","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12876-025-04594-4","volume":"26","author":"J Gu","year":"2026","unstructured":"Gu J, Chai J. An interpretable machine learning model for prediction of significant liver fibrosis in comorbid chronic hepatitis B and nonalcoholic fatty liver disease: a retrospective development and validation study. BMC Gastroenterol. 2026;26(1):116.","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"5290_CR23","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1186\/s12879-023-08632-y","volume":"23","author":"YN Dai","year":"2023","unstructured":"Dai YN, Xu CF, Pan HY, Chen MJ, Yu CH. Fatty liver is associated with significant liver inflammation and increases the burden of advanced fibrosis in chronic HBV infection. BMC Infect Dis. 2023;23(1):637.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"5290_CR24","doi-asserted-by":"publisher","first-page":"101589","DOI":"10.1016\/j.aohep.2024.101589","volume":"30","author":"S Hong","year":"2025","unstructured":"Hong S, Hao Y, Sun L, Li P, Yang J, Zhang F, He L, Zhang J, Wei H. Prevalence and risk factors of significant fibrosis in chronic hepatitis B patients with concurrent metabolic dysfunction-associated steatotic liver disease. Ann Hepatol. 2025;30(2):101589.","journal-title":"Ann Hepatol"},{"issue":"4","key":"5290_CR25","doi-asserted-by":"publisher","first-page":"841","DOI":"10.3350\/cmh.2022.0239","volume":"28","author":"MH Le","year":"2022","unstructured":"Le MH, Yeo YH, Zou B, Barnet S, Henry L, Cheung R, Nguyen MH. Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach. Clin Mol Hepatol. 2022;28(4):841\u201350.","journal-title":"Clin Mol Hepatol"},{"issue":"1","key":"5290_CR26","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1186\/s12889-022-14555-1","volume":"22","author":"Q Cao","year":"2022","unstructured":"Cao Q, Zheng R, He R, Wang T, Xu M, Lu J, Dai M, Zhang D, Chen Y, Zhao Z, et al. Age-specific prevalence, subtypes and risk factors of metabolic diseases in Chinese adults and the different patterns from other racial\/ethnic populations. BMC Public Health. 2022;22(1):2078.","journal-title":"BMC Public Health"},{"issue":"5","key":"5290_CR27","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1097\/MEG.0000000000002741","volume":"36","author":"TH Shen","year":"2024","unstructured":"Shen TH, Wu CH, Lee YW, Chang CC. Prevalence, trends, and characteristics of metabolic dysfunction-associated steatotic liver disease among the US population aged 12\u201379 years. Eur J Gastroenterol Hepatol. 2024;36(5):636\u201345.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"5290_CR28","doi-asserted-by":"publisher","first-page":"101155","DOI":"10.1016\/j.aohep.2023.101155","volume":"29","author":"R Yao","year":"2024","unstructured":"Yao R, Lu S, Xue R, Wang J, Qiu Y, Chen Y, Liu J, Zhu L, Zhan J, Jiang S, et al. NAFLD is associated with less severe liver fibrosis in chronic hepatitis B: A multi-center, retrospective study. Ann Hepatol. 2024;29(1):101155.","journal-title":"Ann Hepatol"},{"issue":"4","key":"5290_CR29","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1007\/s10620-024-08354-4","volume":"69","author":"D Con","year":"2024","unstructured":"Con D, Tu S, Clayton-Chubb D, Lubel JS, Nicoll AJ, Sawhney R, Bloom S. Effect of Concurrent Metabolic Dysfunction-Associated Steatotic Liver Disease on Serial Non-invasive Fibrosis Markers in Chronic Hepatitis B. Dig Dis Sci. 2024;69(4):1496\u2013506.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"5290_CR30","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3138\/canlivj-2024-0038","volume":"8","author":"G Horta","year":"2025","unstructured":"Horta G, Razzak IA, Zhang X, Zhang X, Lai M. Underestimation of Liver Fibrosis Using Vibration-Controlled Transient Elastography on Cirrhosis. Are There Predictors? Can liver J. 2025;8(1):18\u201328.","journal-title":"Can liver J"},{"issue":"3","key":"5290_CR31","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/ajg.2010.463","volume":"106","author":"J Fung","year":"2011","unstructured":"Fung J, Lai CL, Cheng C, Wu R, Wong DK, Yuen MF. Mild-to-moderate elevation of alanine aminotransferase increases liver stiffness measurement by transient elastography in patients with chronic hepatitis B. Am J Gastroenterol. 2011;106(3):492\u20136.","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 1","key":"5290_CR32","first-page":"S10","volume":"59","author":"SK Bansal","year":"2024","unstructured":"Bansal SK, Bansal MB. Pathogenesis of MASLD and MASH - role of insulin resistance and lipotoxicity. Aliment Pharmacol Ther. 2024;59(Suppl 1):S10\u201322.","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"5290_CR33","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1177\/10815589251331892","volume":"73","author":"F Abu Baker","year":"2025","unstructured":"Abu Baker F, Abu Mouch S, Nicola D, Taher Natour R, Shibolet O. Predictors for significant hepatic fibrosis in chronic HBV patients in daily clinical practice: A prospective study. J Invest medicine: official publication Am Federation Clin Res. 2025;73(5):401\u20138.","journal-title":"J Invest medicine: official publication Am Federation Clin Res"},{"issue":"2","key":"5290_CR34","first-page":"147","volume":"79","author":"TD Dao","year":"2025","unstructured":"Dao TD, Tran HV, Nguyen KH, Vu KV. Prevalence and Serological Predictors of Liver Fibrosis in Vietnamese Chronic Hepatitis B Patients with Persistently Normal or Mildly Elevated Aminotransferase Level. Med archives (Sarajevo Bosnia Herzegovina). 2025;79(2):147\u201354.","journal-title":"Med archives (Sarajevo Bosnia Herzegovina)"},{"issue":"9865","key":"5290_CR35","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/S0140-6736(12)61425-1","volume":"381","author":"P Marcellin","year":"2013","unstructured":"Marcellin P, Gane E, Buti M, Afdhal N, Sievert W, Jacobson IM, Washington MK, Germanidis G, Flaherty JF, Aguilar Schall R, et al. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study. Lancet (London England). 2013;381(9865):468\u201375.","journal-title":"Lancet (London England)"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-05290-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-05290-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-05290-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:51:18Z","timestamp":1790668278000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-05290-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5290"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-05290-7","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"assertion":[{"value":"22 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of the Public Health Clinical Center of Chengdu (Approval No. YJ-K2025-87-01). The requirement for informed consent to participate was waived by the Ethics Committee of the Public Health Clinical Center of Chengdu due to the retrospective nature of the study and the use of de-identified clinical data.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"588"}}